Physician profile
Radha Burtch
NPI 1215102892
$4,654.12
in general payments reported to CMS, 2019-2025
36 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,373 · 2020: $108 · 2021: $359 · 2022: $808 · 2023: $137 · 2024: $585 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,930.06 | 2019-2023 | Da Vinci Surgical System |
| Myovant Sciences INC. | $300.91 | 2021-2022 | |
| Pfizer INC. | $183.36 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $159.71 | 2019-2025 | |
| Coopersurgical, INC. | $154.83 | 2019-2025 | Paragard T 380a |
| Gynesonics, INC. | $152.44 | 2022 | |
| Amgen INC. | $130.37 | 2019-2025 | Evenity |
| Hologic Sales and Service, LLC | $123.82 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $104.20 | 2019-2022 | |
| Abbvie INC. | $104.13 | 2019-2022 | |
| Exeltis, USA INC. | $102.62 | 2022-2024 | Slynd |
| Baxter Healthcare | $100.23 | 2025 | Perclot |
| Axonics, INC. | $97.96 | 2024 | Axonics |
| Sumitomo Pharma America, INC. | $97.56 | 2024 | Myfembree |
| Mayne Pharma Commercial LLC | $92.28 | 2022-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $92.01 | 2019 | |
| Avion Pharmaceuticals | $89.31 | 2020-2022 | |
| Agile Therapeutics, INC. | $84.90 | 2021-2024 | Twirla |
| Duchesnay USA Incorporated | $61.25 | 2019 | |
| Organon LLC | $56.63 | 2022 | |
| Astellas Pharma US INC | $53.72 | 2022-2025 | Veozah |
| Allergan, INC. | $40.79 | 2019 | |
| Novo Nordisk INC | $40.66 | 2024 | Wegovy |
| Conmed Corporation | $38.46 | 2023 | Airseal |
| Scynexis, INC. | $33.17 | 2022 | |
| Mylan Pharmaceuticals INC. | $30.86 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $30.82 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.29 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $21.96 | 2024 | Exparel |
| Sanara Medtech INC. | $19.31 | 2021 | |
| Medtronic Vascular, INC. | $18.81 | 2020 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Mimedx Group, INC. | $17.67 | 2025 | |
| Minerva Surgical, INC | $17.42 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.18 | 2019 | |
| Evofem Biosciences, INC. | $14.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radha Burtch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.